Priority Date: 30.01.12 (GB 20120001511)

MODIFIED EPITOPES FOR BOOSTING CD4+ T-CELL RESPONSES

  • Application ID: EP13709300
  • Status: GRANT OF PATENT INTENDED

Applicants

Research organisation logo small
Research Organisation
Research organisation logo small
Research Organisation

Attorneys

Employment test 1 - 10 employees
Company dna iplodge bvba
no operation time available
768.75
Headquarter in Heverlee and 1 office
active in Legal Services, IP Consulting, IP Portfolio Processing, and IP-related Communication Service
Employment test 11 - 50 employees
Company dna de clercq and partners
operating since 1998
Headquarter in Sint-Martens-Latem and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) De Clercq & Partners cvba is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 189 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 30.01.2012 - Priority Date (GB 20120001511)
  • 08.08.2013 - Publication A1 (WO2013113076)
  • 10.12.2014 - Publication A1 (EP2809332)

IPC Classification